Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines
2007
Swainsonine Reduces 5-Fluorouracil Tolerance in Colorectal Cancer Cells
publication
Evidence: moderate
Author Information
Author(s): Hamaguchi Jun, Nakagawa Hiroaki, Takahashi Masato, Kudo Takeaki, Kamiyama Naoya, Sun Bailong, Oshima Takahiro, Sato Yuji, Deguchi Kisaburo, Todo Satoru, Nishimura Shin-Ichiro
Primary Institution: Hokkaido University
Hypothesis
Can swainsonine reduce 5-FU tolerance in colorectal cancer cell lines?
Conclusion
Swainsonine may enhance chemotherapy effectiveness by reducing drug resistance in colorectal cancer cells.
Supporting Evidence
- Swainsonine reduced the IC-50 values of resistant cell lines against 5-FU.
- Different mechanisms of 5-FU resistance were observed in the established cell lines.
- Swainsonine treatment did not affect the sensitivity of the parental cell line to 5-FU.
Takeaway
Swainsonine helps cancer cells respond better to a common drug called 5-FU, making it easier to treat colorectal cancer.
Methodology
The study established various 5-FU resistant cell lines and analyzed the effects of swainsonine on drug sensitivity and N-glycan profiles.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website